NMPA Approval

Bimatoprost Ophthalmic Solution

Approval Number

国药准字HJ20150484

Registration Date

February 17, 2025

Previous Approval Numbers

H20150484

Drug Information

Generic Name

贝美前列素滴眼液

Trade Name

卢美根

Dosage Form

眼用制剂

Strength

3ml:0.9mg

Drug Type

化学药品

Registration Date

February 17, 2025

Expiry Date

February 16, 2030

Company Address

Knollstrasse,67061 Ludwigshafen, Germany

Company Address

Castlebar Road, Westport, County Mayo, Ireland

Empowering clinical research with data-driven insights and AI-powered tools.

贝美前列素滴眼液 - NMPA 批准文号 | MedPath